This strategy allowed independent monitoring by bioluminescence imaging (BLI) and confocal microscopy, of either the whole tumor population or the subpopulation of tumor cells with active GSC promoters CD133 or OCTA4/SOX2. This evidence concerns the gene SOX2 and neoplasm.